| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $368K | -52.2% |
| SG&A Expense | $3.7M | -24.9% |
| Operating Income | -$12.6M | -120.0% |
| Income Tax | $0 | — |
| Net Income | -$12.5M | -124.5% |
| EPS (Basic) | -$129.10 | -2129.7% |
| EPS (Diluted) | -$129.10 | -2129.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.7M | +339.9% |
| Current Assets | $11.0M | +267.7% |
| Total Assets | $11.1M | +265.8% |
| Current Liabilities | $5.2M | +241.9% |
| Total Liabilities | $5.2M | +241.9% |
| Stockholders' Equity | $5.9M | +289.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.8M | -6.7% |
| Investing Cash Flow | $765K | — |
| Financing Cash Flow | $12.3M | +1064.0% |